JACKSONVILLE, Fla. (Ivanhoe Newswire)— It’s a good time of year to focus on our hearts, not just because it’s Valentine’s Day, but because it’s American Heart Month. Coronary heart disease, where ...
FARMINGTON — In an area where heart disease is the second-most common cause of death, finding ways to prevent heart attacks is one of the focuses of the San Juan Regional Medical Center's cardiology ...
This Innovative Bioabsorbable Coating is the First to Complete Absorption Shortly after Drug Elution Ends at Three Months NATICK, Mass., Boston Scientific Corporation received CE Mark approval for the ...
PARIS, Boston Scientific Corporation reports positive results from two trials evaluating new, innovative drug-eluting stent (DES) technologies, which are emerging treatment options for coronary heart ...
Boston Scientific Corporation 's BSX SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) recently won the U.S. Food and Drug Administration (FDA) approval for treating coronary artery ...
Being the first to get the FDA approval for a bioabsorbable polymer drug-eluting stent (BP-DES), Boston Scientific has a huge opportunity to gain share in the interventional cardiology market in the ...
JACKSONVILLE, Fla. (Ivanhoe Newswire)— It’s a good time of year to focus on our hearts, not just because it’s Valentine’s Day, but because it’s American Heart Month. Coronary heart disease, where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results